Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Shoron Mowla

3PUBLICATIONS

49CO-AUTHORS

Haematological tumoursMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 31, 2024

CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells.

Michael R Waarts, Shoron Mowla, Meaghan Boileau

|Jan 17, 2024

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Andrew J Dunbar, Robert L Bowman, Young C Park

|Mar 30, 2021

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.

Raajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara

Pageof 1

Frequent Collaborators

2 joint publications

Sheng F Cai

2 joint publications

Shira E Eisman

2 joint publications

Wenbin Xiao

2 joint publications

Robert L Bowman

2 joint publications

Young C Park

2 joint publications

Kavi O'Connor

2 joint publications

Richard P Koche

2 joint publications

Anthony R Martinez Benitez

2 joint publications

Michael R Waarts

2 joint publications

Inés Fernández-Maestre

Frequent Collaborators

2 joint publications

Sheng F Cai

2 joint publications

Shira E Eisman

2 joint publications

Wenbin Xiao

2 joint publications

Robert L Bowman

Top Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on : May 02, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

See more related videos

Top Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on : May 02, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

See more related videos